4-55953197-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_025009.5(CEP135):c.226G>A(p.Ala76Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000156 in 1,604,314 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_025009.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CEP135 | NM_025009.5 | c.226G>A | p.Ala76Thr | missense_variant | 3/26 | ENST00000257287.5 | |
LOC124900705 | XR_007058124.1 | n.198-726C>T | intron_variant, non_coding_transcript_variant | ||||
CEP135 | XM_006714055.4 | c.226G>A | p.Ala76Thr | missense_variant | 3/26 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CEP135 | ENST00000257287.5 | c.226G>A | p.Ala76Thr | missense_variant | 3/26 | 1 | NM_025009.5 | P1 | |
CEP135 | ENST00000422247.6 | c.226G>A | p.Ala76Thr | missense_variant | 3/6 | 2 | |||
CEP135 | ENST00000706800.1 | n.399G>A | non_coding_transcript_exon_variant | 3/5 |
Frequencies
GnomAD3 genomes AF: 0.0000854 AC: 13AN: 152184Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000289 AC: 7AN: 242038Hom.: 0 AF XY: 0.0000153 AC XY: 2AN XY: 130792
GnomAD4 exome AF: 0.00000826 AC: 12AN: 1452130Hom.: 0 Cov.: 29 AF XY: 0.00000692 AC XY: 5AN XY: 722034
GnomAD4 genome AF: 0.0000854 AC: 13AN: 152184Hom.: 0 Cov.: 33 AF XY: 0.0000538 AC XY: 4AN XY: 74338
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 06, 2021 | The c.226G>A (p.A76T) alteration is located in exon 3 (coding exon 2) of the CEP135 gene. This alteration results from a G to A substitution at nucleotide position 226, causing the alanine (A) at amino acid position 76 to be replaced by a threonine (T). The p.A76T alteration is predicted to be tolerated by in silico analysis. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at